Xia Meng
Corporate Officer/Principal at CELLULAR BIOMEDICINE GROUP, INC.
Profile
Xia Meng is currently the Head-Early Diagnosis & Intervention at AbelZeta Pharma, Inc. Prior to this, Dr. Meng held positions as the Head-Institute Merieux Laboratory at Fudan University Shanghai Cancer Center, and as the General Manager at both Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
and Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd.
Dr. Meng completed an undergraduate degree at Wuhan University and a doctorate degree at Université Pierre et Marie Curie.
Xia Meng active positions
Companies | Position | Start |
---|---|---|
CELLULAR BIOMEDICINE GROUP, INC. | Corporate Officer/Principal | 06/02/2018 |
Former positions of Xia Meng
Companies | Position | End |
---|---|---|
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. | Corporate Officer/Principal | - |
Fudan University Shanghai Cancer Center
Fudan University Shanghai Cancer Center Pharmaceuticals: OtherHealth Technology Fudan University Shanghai Cancer Center is a cancer center that operates in Shanghai, CN. The center was founded in 1931. | Corporate Officer/Principal | - |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Corporate Officer/Principal | - |
Training of Xia Meng
Wuhan University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 5 |
---|---|
Université Pierre et Marie Curie | Consumer Services |
Fudan University Shanghai Cancer Center
Fudan University Shanghai Cancer Center Pharmaceuticals: OtherHealth Technology Fudan University Shanghai Cancer Center is a cancer center that operates in Shanghai, CN. The center was founded in 1931. | Health Technology |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Commercial Services |
AbelZeta Pharma, Inc.
AbelZeta Pharma, Inc. BiotechnologyHealth Technology Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in Rockville, MD. | Health Technology |
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. |
- Stock Market
- Insiders
- Xia Meng